×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Advancing Clinical Outcomes through Digital Health Technology Innovation
Session Chair(s)
Representative Invited
FDA, United States
Digital health technologies are advancing drug development, aligning with FDA's PDUFA VII commitments. This session explores their impact, featuring perspectives from academia, industry, and FDA.
Learning Objective : Describe the evolving application and impact of digital health technologies in clinical research; Identify best practices for integrating digital health technologies with traditional clinical outcome assessments; Discuss the challenges and regulatory considerations associated with the use of digital health technologies.
Speaker(s)
The Moment of Change
Representative Invited
FDA, United States
Industry Perspective
Sooyoon Shin, PhD
Verily, United States
Senior Manager, Digital Biomarkers
Industry Perspective
Tarik Yardibi, PhD
Takeda Pharmaceuticals, United States
Director, Sensing and Measurement
Academic Perspective
Vadim Zipunnikov
Johns Hopkins Bloomberg School of Public Health, United States
Associate Professor
Have an account?